Tempus listed on Nasdaq, filed disclosures with the SEC, and received research reports from Jefferies Financial Group.
7 reports, 3 independent
Updated Sep 19
Gone quiet
- Reports
- 7
- Developments
- 5
- Repetition
- 29%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tempus listed on Nasdaq, filed disclosures with the SEC, and received research reports from Jefferies Financial Group.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Tempus is seeking expanded Medicare reimbursement revenue following its listing on Nasdaq.1 source
Director Nadja West sold shares of Tempus AI stock.1 source
Successful Phase 3 trial results shared after listing on Nasdaq.1 source
Jefferies initiated coverage and TD Cowen reiterated a buy rating on Tempus AI.1 source
Tempus filed SEC disclosures and received research reports from Jefferies Financial Group.1 source
Keep exploring
The entities involved
-
Tempus
biotechnology company based in Chicago, Illinois
-
Nasdaq
American fully electronic stock exchange
-
SEC
Slovak company
Related events
- Tetra Tech was listed on the electronic stock exchange on August 25, 2026.
- Affirm listed on the Nasdaq stock exchange, filed disclosures with the SEC, and received research reports from Needham & Company.
- Precigen, Inc. listed on the Nasdaq stock exchange and filed disclosures with the SEC on August 25, 2026.
- Establishment Labs filed with the SEC and was listed on the Nasdaq stock exchange on August 29, 2026.
- Global Interactive Technologies, Inc. was listed on the electronic stock exchange and required to file disclosures with the SEC on August 15, 2026.